Because it was shown that oxidants can amplify GSIS and persistent activation of Nrf2 decreases glucose-triggered ROS signaling insulin release, this study points out on distinct roles that Nrf2 may play in pancreatic β-cell dysfunction that accompanies different stages of diabetes. The gene discussed is NFE2L2; the disease is diabetes mellitus.